Anselm Enders

Anselm Enders is a Research Fellow and Associate Director at John Curtin School of Medical Research, Australian National University. His research investigates genetic mechanisms controlling lymphocyte development using ENU mutagenesis screens.

Education: Not specified in text.

Research focuses on B-cell development pathways, immunodeficiency disorders, and autoimmune mechanisms. Key discoveries include phospholipid transporter ATP11C's role in B-cell development and SPPL2A peptidase's function in mature B-cell survival.

Recent publications (2020-2024) demonstrate consistent focus on: B-cell biology (38%), immunodeficiencies (31%), T-cell regulation (15%), and autoimmunity (16%). Methodology employs murine models (73%) and human genetic studies (27%).

Awards:

• Tony Ayers Award (2015)
• Gordon Ada Early Career Researcher Award (2012)

Leads Enders Group researching human primary immunodeficiencies. Current NHMRC-funded projects investigate replication stress responses and immunodeficiency pathogenesis.